RxDoctor Payments Data

Lindsey Morgan

Psychiatric/Mental Health · Noblesville, INNPI 1265994180

Payments from drug & device makers

$338in general payments, 2019–2025

Across 13 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$100
  • Axsome Therapeutics, Inc.$49
  • Corium, LLC$44
  • Otsuka America Pharmaceutical, Inc.$32
  • Johnson & Johnson$31
  • Hologic Sales And Service, LLC$23
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$338 in reported general payments places this provider in the 40th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$9,650
Medicare patients
18
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate38$135,851
VraylarCariprazine Hcl16$38,263
Bupropion XlBupropion Hcl56$11,163
TrintellixVortioxetine Hydrobromide16$10,501
Paliperidone ErPaliperidone31$5,947
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl28$5,747
Aripiprazole37$5,464
Desvenlafaxine Succinate ErDesvenlafaxine Succinate24$1,866
Olanzapine22$1,795
Quetiapine Fumarate ErQuetiapine Fumarate50$1,678
Divalproex Sodium ErDivalproex Sodium18$1,250
Duloxetine Hcl61$1,166
Gabapentin89$1,159
Hydroxyzine Hcl42$990
Lamotrigine102$932

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$31$135,85138 claims
AbbVieVraylar$14$38,26316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Noblesville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →